Research progress on the mechanisms of microglial extracellular vesicles affecting the prognosis of ischemic stroke

Yang An1, Gang Su2, Wei Chen1

  • 1Department of Neurology, Lanzhou University Second Hospital, 730030 Lanzhou, Gansu, China.

PubMed

Insights

Microglia-derived extracellular vesicles show promise in treating ischemic stroke. These vesicles deliver therapeutic cargo to reduce brain damage and promote recovery after stroke.

Area of Science:

  • Neuroscience
  • Immunology
  • Cell Biology

Background:

  • Ischemic stroke is a leading cause of death and disability globally.
  • Microglia, the brain's immune cells, play a critical role in stroke pathology and repair.
  • Microglia-derived extracellular vesicles are key mediators of neuroprotection and recovery.

Purpose of the Study:

  • To review recent advancements in understanding microglia-derived extracellular vesicles in ischemic stroke.
  • To discuss their therapeutic mechanisms and potential for improving stroke prognosis.

Main Methods:

  • A comprehensive literature search was conducted on PubMed and Web of Science.
  • Keywords included "ischemic stroke" and "microglia-derived extracellular vesicles/exosomes".
  • 59 relevant articles were included in this review.

Main Results:

  • Microglia release extracellular vesicles containing proteins, nucleic acids, and metabolites post-stroke.
  • These vesicles exert neuroprotective effects by reducing neuronal apoptosis, autophagy, ferroptosis, and pyroptosis.
  • They also alleviate inflammation, reduce glial scarring, promote myelin repair, and aid blood-brain barrier restoration.

Conclusions:

  • Microglia-derived extracellular vesicles represent a promising therapeutic strategy for ischemic stroke.
  • Further research into their mechanisms can lead to improved stroke treatment and patient outcomes.